Abbreviations used in this paper: DIC, differential interference contrast; FRET, fluorescence resonance energy transfer; ICAM, intercellular adhesion molecule; IRM, interference reflection microscopy; LFA-1, leukocyte function--associated molecule-1; ROI, region of interest.

Introduction
============

Regulation of the adhesiveness of the integrin leukocyte function--associated molecule-1 (LFA-1) is critical for dynamic immune system functions such as leukocyte trafficking, migration within tissues, and formation of immunological synapses. The overall strength (or "avidity") of cellular adhesive interactions results from the combination of both the affinity of individual receptor--ligand bonds and the total number of bonds formed, i.e., the "valency" of the interaction. Affinity regulation of integrins refers to changes in individual αβ heterodimer affinity that are coupled to alterations in integrin conformation, whereas valency regulation is mediated by changes in cell surface receptor diffusivity or local density that alter the number of adhesive bonds that can form ([@bib9]; [@bib21]; [@bib2]; [@bib37]; [@bib39]; [@bib5]; [@bib13]). The leukocyte integrin LFA-1 (lymphocyte function-associated antigen-1; α~L~β~2~) is perhaps the most widely studied integrin with respect to affinity and valency regulation. The cell surface ligands recognized by LFA-1 are members of the Ig superfamily known as intercellular adhesion molecules (ICAMs) and are expressed on a wide variety of somatic cells, and in the case of ICAM-1 are inducible by inflammatory cytokines ([@bib35]; [@bib7]).

Integrins are heterodimeric receptors, consisting of α and β subunits that together form a globular, ligand-binding head region and individually form two legs that connect to the transmembrane and cytoplasmic domains of each subunit. In the low affinity integrin conformation the head folds over the legs owing to a bend at the knees, whereas the high affinity conformation is extended ([@bib33]). Transition to the extended state involves separation of the α and β subunits at their cytoplasmic, transmembrane, and leg domains ([@bib38]; [@bib42]; [@bib15]; [@bib25]). These events lead to disruption of the association between the integrin head and legs, and a switchblade-like extension ([@bib38]). These global conformational changes are coupled to specific inter- and intra-domain rearrangements that stabilize the high affinity states of the β I-like and α I domains in the head region ([@bib33]; [@bib43]; [@bib44]).

Valency regulation is operationally defined, in part, by fluorescence microscopy--based observation of changes in integrin cell surface distribution. Though collectively referred to as "clustering," reported redistribution patterns are variable, including large, dot-like unevenly distributed clusters ([@bib40], [@bib41]), polarized patches on one side of the cell surface ([@bib6]; [@bib28]), and differential concentration of LFA-1 to the leading and trailing portions of polarized or migrating cells ([@bib13]). Clustering has also been reported when the distribution appears even, and fluorescence measurements by microscopy differ from those by flow cytometry ([@bib37]; [@bib27]). In practice, valency regulation has also been inferred when activators promote cell adhesion without promoting direct soluble ligand binding. However, more sensitive ligand displacement assays can detect an increase in affinity with some such activators, i.e., PMA ([@bib21]).

The nature of integrin "clusters," what drives their formation, and their role in dynamic adhesions remain unclear ([@bib5]). Integrins on leukocytes can be activated with chemokines or agents that mimic inside-out signals, such as PMA, and adhesion can also be stimulated by agents that disrupt the actin cytoskeleton ([@bib10]; [@bib16]; [@bib46]; [@bib29]). PMA and cytoskeleton-disrupting agents also increase diffusion of integrins in the cell membrane ([@bib10]; [@bib16]; [@bib46]; [@bib47]). Thus, one possibility is that increased integrin diffusivity acts simply to facilitate ligand-dependent, mass-action--driven accumulation of integrins into the site of contact with multivalent ligand-bearing substrates, functioning in "adhesion strengthening" ([@bib16]). It is noteworthy that all leukocytes that express LFA-1 also express one or more of its ligands, ICAM-1, ICAM-2, and ICAM-3, and that activation of LFA-1 often leads to formation of aggregates of homotypically adherent cells ([@bib35]; [@bib7]). Thus, ligand-dependent redistribution, as a consequence of binding to ICAMs on adjacent cells in homotypic aggregates that are disrupted before experimental observation by fluorescence microscopy, is one of several plausible explanations for observations of LFA-1 clustering ([@bib5]).

An alternative hypothesis is that release of cytoskeletal constraints is rapidly followed by, or coupled to, intrinsic proactive induction of cell surface integrin clusters or oligomers in a ligand-independent manner, and serves to enhance the propensity to form initial adhesions with multivalent substrates ([@bib2]; [@bib41]; [@bib6]; [@bib39]; [@bib11]; [@bib19]). One of the proposed mechanisms for proactive integrin clustering involves the regulated recruitment of integrins into lipid raft domains ([@bib11]). In addition, based on the observation that peptides containing integrin α and β subunit transmembrane domains form homodimers and homotrimers in detergent micelles, it has also been suggested that transition of integrins to an extended conformation, and particularly separation of the α and β subunit cytoplasmic and transmembrane domains, is sufficient to drive microclustering by facilitating homomeric associations between the transmembrane domains of neighboring integrins ([@bib18], [@bib19]).

In this paper we establish fluorescence resonance energy transfer (FRET) and high resolution confocal fluorescence microscopy as quantitative methods for the analysis of LFA-1 distribution. Because the resolution scale of FRET and light microscopy differ by at least two orders of magnitude, we distinguish clustering data obtained by these two techniques as "microclustering" (scale of tens of angstroms) and "macroclustering" (scale of \>200 nm). Importantly, the presence of macroclusters does not necessitate the existence of microclusters, and vice versa. Therefore, light microscopy and FRET microscopy should be considered complementary techniques. In parallel with cell adhesion, soluble ligand binding, and activation epitope exposure assays, we have addressed two central and longstanding questions: First, is rapid LFA-1 redistribution or clustering actively driven in cells, functioning to increase the propensity to form initial adhesions, or does it occur subsequent to formation of initial adhesions, in a mass-action--dependent manner, functioning primarily in adhesion strengthening? And second, is the conformation of LFA-1 linked to macro- or microclustering?

Results
=======

To quantitatively measure integrin clustering on the cell surface at the scale of molecular interactions, i.e., microclustering, we developed FRET-based assays. Nondimerizing or "monomeric" (m) mutants ([@bib45]) of CFP (mCFP) and YFP (mYFP) were fused to the COOH termini of the α~L~ and β~2~ subunit cytoplasmic domains ([Fig. 1](#fig1){ref-type="fig"} A). To measure inter-heterodimer distances, K562 cells were transiently transfected with α~L~-mCFP, α~L~-mYFP, and wild-type β~2~, generating cell surface expression of α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ in approximately equal amounts. The redistribution of integrin heterodimers into microclusters, in which the α~L~ subunits come within 100 Å of each other, should result in detectable CFP/YFP FRET. Similarly, cells were transfected with wild-type α~L~, β~2~-mCFP and β~2~-mYFP, such that FRET would measure proximity of β~2~ subunits of separate integrin heterodimers.

![**Experimental design and validation of inter-heterodimer FRET microclustering assay.** (A) A hypothetical model ([@bib19]) for integrin clustering. Cells expressing heterodimers with either the α (shown) or β subunits tagged with both mCFP and mYFP will exhibit FRET only when heterodimers are brought into close proximity (\< 100 Å). (B) Schematic (top) and model curves (bottom) for FRET behavior under nonclustered and microclustered conditions ([@bib14]; [@bib45]). See Results. (C--G) Inter-heterodimer FRET and acceptor intensities for individual ROIs from K562 cells expressing α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ (C and E), α~L~-CFP/β~2~ and α~L~-YFP/β~2~ (D), or α~L~/β~2~-mCFP and α~L~/β~2~-mYFP (F and G) were fit to $\documentclass[10pt]{article}
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\begin{equation*}{\mathrm{Eq}}.\;2\end{equation*}\end{document}$ (red curves) using the Lineweaver-Burke equation as described in Materials and methods. Where indicated, cell surface LFA-1 was cross-linked by preincubation with either 10 μg/ml of TS2/4 mAb to α~L~ (E) or CBR LFA-1/7 mAb to β~2~ (G) and secondary, purified goat anti--mouse antibody (10 μg/ml) for 30 min at 37°C. Representative confocal images, depicting the YFP signal from selected experiments (C--E), are shown below the graphs.](200404160f1){#fig1}

For nonclustered molecules, the relationship between cell surface density and FRET is largely linear ([@bib14]; [@bib45]) ([Fig. 1](#fig1){ref-type="fig"} B). By contrast, microclustered molecules are in close proximity to one another, and therefore exhibit FRET at lower densities ([@bib14]; [@bib45]) ([Fig. 1](#fig1){ref-type="fig"} B). This relationship has been expressed as a saturable one-site binding model, $$\documentclass[10pt]{article}
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\begin{equation*}E=E_{{\mathrm{max}}}{\times}{F}/{ \left \left(F+K\right) \right }{\mathrm{,}}\end{equation*}\end{document}$$where FRET efficiency (*E*) is a hyperbolic function of the cell surface density (*F*), which is usually taken from the fluorescence intensity of the directly excited acceptor (YFP), and *K* is analogous to the dissociation constant of microclusters ([@bib45]). Thus, the lower the *K* value, the greater the tendency to cluster. Clustering becomes predominant when *F* \> *K* ([@bib45]).

Under basal conditions, α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~, or α~L~/β~2~-mCFP and α~L~/β~2~-mYFP, showed largely linear FRET/acceptor density relationships and very large *K* values of 1558 ± 430 and 1871 ± 515, respectively, suggesting little microclustering ([Fig. 1](#fig1){ref-type="fig"} C, top, and [Fig. 1](#fig1){ref-type="fig"} F). High resolution confocal microscopy imaging also demonstrated a lack of LFA-1 macroclustering ([Fig. 1](#fig1){ref-type="fig"} C, bottom). However, cross-linking of LFA-1 with antibodies to α~L~ or β~2~ and polyclonal anti-Ig produced readily detectable microclustering between α~L~ subunits ([Fig. 1](#fig1){ref-type="fig"} E; *K* = 66 ± 29) and between β~2~ subunits ([Fig. 1](#fig1){ref-type="fig"} G; *K* = 76 ± 56). Furthermore, antibody cross-linking also induced macroclustering ([Fig. 1](#fig1){ref-type="fig"} E, bottom). In contrast to monomeric mCFP and mYFP mutants, CFP and YFP have a tendency to dimerize ([@bib45]). When cells were transfected with constructs containing CFP and YFP (α~L~-CFP/β~2~ and α~L~-YFP/β~2~), an intermediate level of microclustering occurred ([Fig. 1](#fig1){ref-type="fig"} D, top; *K* = 532 ± 72). This microclustering occurred in the absence of detectable macroclustering ([Fig. 1](#fig1){ref-type="fig"} D, bottom). The results with microclustering induced by antibody and dimerizing CFP and YFP variants demonstrate a wide dynamic range of sensitivity for our FRET assay.

We used ligand-induced activation of LFA-1 to test for a linkage between changes in integrin conformation, specifically separation of α and β subunit cytoplasmic domains within a heterodimer ([@bib15]), and the formation of clusters of LFA-1 molecules through homomeric interaction ([@bib19]). Mn^2+^ has been shown to promote conformational changes in the extracellular domain of LFA-1 that increases its affinity for ICAM-1 ([@bib8]). Mn^2+^-promoted binding of ICAM-1 to LFA-1 induces separation of the α~L~ and β~2~ cytoplasmic domains ([@bib15]), as confirmed here with intra-heterodimer FRET using α~L~-mCFP/β~2~-mYFP transfectants (Fig. S1 A, available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>). By contrast, parallel inter-heterodimer α~L~-α~L~ FRET experiments showed absolutely no microclustering promoted with Mn^2+^ plus sICAM-1 using α~L~-mCFP/β~2~ + α~L~-mYFP/β~2~ transfectants ([Fig. 2](#fig2){ref-type="fig"} A, Mn^2+^ + sIC compared with Mn^2+^). Similarly, Mn^2+^ plus sICAM-1 did not promote any β~2~-β~2~ FRET in the α~L~/β~2~- mCFP + α~L~/β~2~-mYFP transfectants ([Fig. 2](#fig2){ref-type="fig"} B). Mn^2+^ + sICAM-1 also failed to induce macroclustering (Fig. S1 C).

![**Multimeric ligand binding to activated LFA-1 but not activation alone induces LFA-1 microclustering.** K562 cells expressing α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ (A), α~L~/β~2~-mCFP and α~L~/β~2~-mYFP (B), or α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ + CXCR4 (C) were preincubated with either 1 mM Mn^2+^, 1 mM Mn^2+^ + 100 μg/ml sIC-1, IC-Fc/Anti-IgA complex, 1 mM Mn^2+^ + IC-Fc/Anti-IgA complex, 1 μg/ml SDF-1, 1 μg/ml SDF-1 + 500 μg/ml sIC-1, or 1 μg/ml SDF-1 + IC-Fc/Anti-IgA complex, and were subjected to FRET measurements.](200404160f2){#fig2}

Clustering with multimeric ICAM-1 was tested using ICAM-1-Fcα chimera/anti-IgA immune complexes, which bind strongly to LFA-1--bearing cells in Mn^2+^ (Fig. S1 B). Binding of oligomeric ICAM-1 induced robust microclustering of LFA-1 in the presence of Mn^2+^ as measured by both FRET between α~L~ subunits ([Fig. 2](#fig2){ref-type="fig"} A; *K* = 63 ± 17) and FRET between β~2~ subunits ([Fig. 2](#fig2){ref-type="fig"} B; *K* = 51 ± 24), but did not induce detectable macroclustering (Fig. S1 C). Thus, stabilization of the extended, high affinity integrin conformation by soluble monomeric ligand is insufficient to induce either micro- or macroclustering of LFA-1, whereas binding of soluble multivalent ligand promotes efficient microclustering but not macroclustering.

To assess the effect of chemokine receptor signaling on the clustering of LFA-1, K562 cells were transiently transfected with α~L~-mCFP, α~L~-mYFP, wild-type β~2~, and HA-tagged CXCR4. HA-CXCR4 transfectants were identified by immunofluorescence with anti-HA antibody and Cy5-labeled anti-Ig (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>). Addition of the chemokine SDF-1 only or SDF-1 plus sICAM-1 did not promote FRET in the α~L~-mCFP/β~2~ + α~L~-mYFP/β~2~ + CXCR4 transfectants ([Fig. 2](#fig2){ref-type="fig"} C). By contrast, SDF-1 induces separation of the α~L~ and β~2~ cytoplasmic domains in α~L~-mCFP/β~2~-mYFP + CXCR4 transfectants ([@bib15]). SDF-1 + sICAM-1 also failed to induce macroclustering (unpublished data). However, addition of SDF-1 + oligomeric ICAM-1 induced robust microclustering of LFA-1 ([Fig. 2](#fig2){ref-type="fig"} C) without detectable macroclustering (Fig. S2 and Video 1, available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>).

Valency-based modes of integrin regulation are known to act, at least in part, through increasing integrin cell surface diffusivity ([@bib16]; [@bib47]). Cytochalasin D and latrunculin A have been used previously to dissect integrin regulatory mechanisms, and are thought to act by selectively increasing integrin diffusivity without altering conformation ([@bib16]; [@bib39]; [@bib47]). PMA has been reported both to modulate affinity and to increase diffusivity ([@bib21]; [@bib16]; [@bib47]). Consistent with previous reports ([@bib16]; [@bib39]; [@bib47]), cell pretreatment with 1 μM cytochalasin D or 1 μM latrunculin A caused partial disruption of actin filaments in K562 cells (Fig. S3, available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>) and significantly increased LFA-1 lateral mobility (Fig. S4) as measured by Alexa 488--phalloidin staining and FRAP, respectively. The same concentrations of cytochalasin D and latrunculin A induced significant adhesion in both V-bottom ([Fig. 3](#fig3){ref-type="fig"} A) and conventional flat-bottom well ([Fig. 3](#fig3){ref-type="fig"} B) assays, which was comparable to that induced by 1 mM Mn^2+^. Substantial adhesion promoted by 1 μM PMA was readily detected by the V-bottom assay ([Fig. 3](#fig3){ref-type="fig"} A), but not by the less sensitive flat-bottom assay ([Fig. 3](#fig3){ref-type="fig"} B). In the flat-bottom assay cells are washed with high shear, whereas in the V-bottom assay nonadherent cells are separated by centrifugation and there is no washing. Adhesion stimulated by cytochalasin D was further analyzed under physiologic shear conditions in a parallel wall flow chamber ([Fig. 3, C and D](#fig3){ref-type="fig"}). Cytochalasin D promoted significant amounts of highly shear-resistant cellular adhesions either with ([Fig. 3](#fig3){ref-type="fig"} C) or without ([Fig. 3](#fig3){ref-type="fig"} D) brief precentrifugation to promote initial contacts, and was only somewhat less effective than Mn^2+^.

![**Disruption of cytoskeletal constraints enhances cell adhesion but does not promote soluble ligand binding or conformational change.** (A and B) K562 transfectants expressing wild-type α~L~β~2~ were preincubated with Mn^2+^, PMA, cytochalasin D, or latrunculin A in the absence or presence of inhibitory α~L~ mAb TS1/22 (10 μg/ml) and allowed to bind ICAM-1 immobilized on V-bottom (A) or flat-bottom (B) plates, as described in Materials and methods. Data represent mean ± SEM of all measurements from three independent experiments in duplicate (A) or three independent experiments in triplicate (B). (C and D) Stable K562 cell transfectants expressing wild-type α~L~β~2~ were allowed to adhere, with (C) and without (D) an initial centrifugation, to coverslips coated with ICAM-1 in the absence (Control) or presence of 1 mM Mn^2+^ or 1 μM cytochalasin D for 30 min at 37°C under static conditions. Coverslips were transferred to a laminar flow chamber and cells were then detached by a shear regimen of 30 s each of 0, 2, 4, 8, 16, and 32 dyn/cm^2^. The number of cells remaining after each interval were counted. Values are mean ± SEM for three separate experiments. (E) Binding of soluble, multimeric ICAM-1-Fcα chimera/anti-IgA-FITC complex was conducted in the presence of Mn^2+^, PMA, cytochalasin D, or latrunculin A at 37°C and measured by flow cytometry. Data show mean ± SEM of three experiments, each in triplicate. (F) Binding of conformation-sensitive antibodies KIM127 and m24 in the absence or presence of Mn^2+^, PMA, cytochalasin D, or latrunculin A was measured by immunofluorescence flow cytometry. A representative of three separate experiments is shown.](200404160f3){#fig3}

In contrast to adhesion, but consistent with previous reports ([@bib36]), significant binding of soluble multimeric ICAM-1 was only observed with Mn^2+^ treatment ([Fig. 3](#fig3){ref-type="fig"} E). Similarly, binding of the activation-dependent antibody KIM127, which recognizes a portion of the β2 EGF2 domain that is buried in the bent conformation and exposed in the extended conformation ([@bib23]; [@bib3]), and m24, which recognizes the active conformation of the β~2~ I-like domain ([@bib24]), was strongly induced by Mn^2+^, but not by cytochalasin D or latrunculin A ([Fig. 3](#fig3){ref-type="fig"} F). Consistent with our previous observations ([@bib23]; [@bib15]), PMA exposed the epitope for KIM127 but not m24 ([Fig. 3](#fig3){ref-type="fig"} F), suggesting a partial ability to modulate integrin conformation.

To determine whether actin-disrupting agents or PMA directly alter LFA-1 distribution patterns, we conducted confocal ([Fig. 4](#fig4){ref-type="fig"}) and FRET ([Fig. 5](#fig5){ref-type="fig"}) microscopy studies. Cross-linking cell surface LFA-1 with primary and secondary antibodies efficiently promoted LFA-1 macroclustering; however, treatment with cytochalasin D, latrunculin A, and PMA did not ([Fig. 4](#fig4){ref-type="fig"} and unpublished data). Some alteration in the shape of PMA-treated cells was attributable to the ability of PMA to induce bleb formation in K562 cells ([@bib30]), as confirmed by differential interference contrast (DIC) imaging (unpublished data). The amount of FRET between LFA-1 heterodimers in PMA- and cytochalasin D--treated cells measured either between αL subunits ([Fig. 5](#fig5){ref-type="fig"} A) or between β~2~ subunits ([Fig. 5](#fig5){ref-type="fig"} B) was similar to that in untreated cells ([Fig. 1, C and F](#fig1){ref-type="fig"}). This demonstrated an absence of significant microclustering induced by treatment with PMA or cytochalasin D. Thus, release of cytoskeletal constraints enables robust adhesion to ICAM-1 substrates, but does not drive ligand-independent integrin macro- or microclustering.

![**Disruption of cytoskeletal constraints does not alter LFA-1 macroclustering.** (A--D) K562 cells expressing wild-type α~L~β~2~ were incubated in (A) L15 medium (control); (B) 1 mM Mn^2+^; (C) 1 μM PMA; or (D) 1 μM cytochalasin D for 30 min at 37°C. After fixation, cells were stained with Cy3-conjugated TS2/4 mAb. (E) Cells were incubated with Cy3-TS2/4 mAb (10 μg/ml) together with purified anti--mouse IgG (10 μg/ml) at 37°C for 30 min followed by fixation. All cells (A--E) were then plated on coverslips and subjected to confocal microscopy. Center panels depict a threefold magnification of the boxed regions shown in the left panels. Three-dimensional histograms of fluorescence intensity and cell surface distribution are shown in the right panels.](200404160f4){#fig4}

![**Disruption of cytoskeletal constraints does not alter LFA-1 microclustering.** Inter-heterodimer FRET between α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ (A) or α~L~/β~2~-mCFP and α~L~/β~2~-mYFP (B) was measured after 1 μM PMA or 1 μM cytochalasin D pretreatment for 30 min at 37°C, as indicated.](200404160f5){#fig5}

Based on these results and the finding above that binding of multivalent, soluble ICAM-1 in the presence of either Mn^2+^ or SDF-1 can drive microcluster formation, we hypothesized that agents that increase diffusivity regulate adhesion primarily by enhancing accumulation of LFA-1 into the zone of contact with ICAM-1 substrates. Examination of the contact zone itself by interference reflection microscopy (IRM) revealed that cytochalasin D--treated cells formed markedly larger contacts (P \< 0.01) on ICAM-1 substrates than Mn^2+^-treated cells ([Fig. 6, A and B](#fig6){ref-type="fig"}). PMA-treated cells formed contact zones of intermediate size that were also significantly (P \< 0.01) larger than those of Mn^2+^-treated cells. Furthermore, control cells that received no pretreatment failed to form significant contacts on ICAM-1 substrates ([Fig. 6, A and B](#fig6){ref-type="fig"}). Application of force by centrifugation did not alter the pattern of the contact zone or increase the overall contact area, suggesting that differences in contact zones were not a consequence of differential cell deformability. Fluorescence confocal microscopy revealed that the distribution of LFA-1 was not detectably different among Mn^2+^-, PMA-, cytochalasin D--, and latrunculin A--treated cells at planes above the cell--substrate contact interface ([Fig. 6](#fig6){ref-type="fig"} C, middle). However, at the plane of contact, significantly (P \< 0.01) greater total accumulation of LFA-1 was observed with cytochalasin D-- and latrunculin A--treated cells than with Mn^2+^-treated cells ([Fig. 6](#fig6){ref-type="fig"} C, bottom). Compared with Mn^2+^-treated cells, cytochalasin D-- and latrunculin A--treated cells accumulated 5.7- and 7.2-fold more LFA-1 in the substrate contact zone, respectively, whereas PMA-treated cells exhibited a 1.5-fold increase ([Fig. 6](#fig6){ref-type="fig"} C).

![**Cytoskeleton disruption leads to accumulation of LFA-1 to the zone of ICAM-1 substrate contact.** (A and B) Stable K562 cell transfectants expressing wild-type α~L~β~2~ were allowed to adhere, with (A) and without (B) initial centrifugation, to coverslips coated with ICAM-1 or BSA in the absence (Control) or presence of 1 mM Mn^2+^, 1 μM PMA, or 1 μM cytochalasin D as indicated for 30 min at 37°C. Cells were then fixed and subjected to IRM (top left panels) and DIC (top right panels). The zone including all IRM contacts for each cell was outlined and the area calculated by OpenLab software (bottom panels). Each symbol represents one cell. Bar = mean. \*, P \< 0.01 vs. Mn^2+^-treated cells. (C) Cells were prepared as in A and then were additionally subjected to staining with mAbs CBR LFA-1/7-Cy3 to β~2~ and TS2/4-Cy3 to α~L~ followed by anti--mouse IgG-Cy3 to maximize the fluorescent signal. Samples were then analyzed by serial sectioning (0.5 μm Z-step) confocal microscopy. Images represent either the top view of the three-dimensional image reconstruction for "All" of the sections, or individual sections taken from the "Middle" or "Bottom" (at the ICAM-1 substrate contact interface) planes. Fluorescence intensity of LFA-1 staining in the "Bottom" section was plotted in the three-dimensional histogram of "LFA-1 density". The LFA-1 accumulation index (AI) was calculated as (total number of pixels in the contact area × mean intensity of those pixels)/(10^6^). AI = mean ± SEM for nine cells. \*, P \< 0.01 vs. Mn^2+^-treated cells.](200404160f6){#fig6}

The size of the contact zone and accumulation of LFA-1 ([Fig. 6](#fig6){ref-type="fig"}) were quantitated in parallel, and under exactly the same conditions, as the characterization of resistance to detachment in shear flow described in [Fig. 3, C and D](#fig3){ref-type="fig"}. Notably, Mn^2+^-treated cells were more resistant to shear than cytochalasin D-- or latrunculin A--treated cells despite the smaller contact areas and lower amount of LFA-1 accumulation, consistent with evidence that Mn^2+^ increases the affinity of LFA-1 for ICAM-1.

Many cell types, including K562 cells, and all leukocytes that express LFA-1 also express one or more of its ligands, the ICAMs, facilitating formation of aggregates of homotypically adherent cells ([@bib35]; [@bib7]). In all experiments described above, we avoided homotypic adhesion by activating cells at low density. Furthermore, cells were vigorously resuspended, allowed to settle, and incubated at 37°C for 10 min before fluorescence measurements to ensure that even if some preexisting homotypic adhesion had occurred, that the distribution of LFA-1 had equilibrated for 10 min after the cells were monodisperse. Under these conditions on ICAM-1 substrates, no homotypic adhesion occurred between neighboring K562 transfectants, as confirmed by the lack of redistribution of LFA-1 ([Fig. 6](#fig6){ref-type="fig"} C, middle). However, when K562 transfectants were incubated at high cell densities with Mn^2+^, PMA, or cytochalasin D under conditions similar to those previously reported to lead to macroclustering of LFA-1, significant homotypic adhesion occurred ([Fig. 7](#fig7){ref-type="fig"} A). Furthermore, marked macroclustering of LFA-1 was found at sites of cell--cell contact between homotypically adherent cells, whether stimulated with Mn^2+^, PMA, or cytochalasin D ([Fig. 7](#fig7){ref-type="fig"} B). Moreover, LFA-1 was present in microclusters at the cell--cell contact zone, as revealed by inter-heterodimer FRET ([Fig. 7](#fig7){ref-type="fig"} B, bottom). Notably, LFA-1 present outside the region of cell--cell contact was not microclustered.

![**Homotypic cell aggregation promotes LFA-1 macro- and microclustering at the cell--cell contact interface.** (A) K562 transfectants expressing wild-type α~L~β~2~ in 1.5-ml microfuge tubes (10^6^ cells in 100 μl L15 medium + 2 mg/ml glucose) were centrifuged at 200 *g* for 30 s and incubated in the absence (control) or presence of 1 mM Mn^2+^, 1 μM PMA, or 1 μM cytochalasin D for 1 h at 37°C, transferred to cell culture dishes, and imaged by phase-contrast microscopy using a 10× objective in the original experiment. (B) Transient α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ K562 transfectants were treated exactly as in A, and inter-heterodimer FRET was measured for homotypically adherent cells. DIC (top), CFP fluorescence after YFP bleaching (middle), and pixel-by-pixel FRET efficiency (from 0 \[black\] to 0.2 \[red\]) (bottom) are shown. (C and D) K562 transfectants stably expressing α~L~-mCFP/β~2~-mYFP and the talin head domain ([@bib15]) were gently removed from culture flasks and either directly plated on cover glasses and imaged with YFP fluorescence (C) or micropipetted 5--10 times to obtain single suspensions, plated, and incubated for 10 min before imaging YFP fluorescence (D). (E) Aggregates of K562 transfectants expressing α~L~-mCFP/β~2~-mYFP and the talin head domain were dissociated as in D and immediately subjected to time-lapse fluorescence imaging at 37^ο^C. (F) To observe the formation of macroclusters, cells treated as in D were allowed to reestablish homotypic cell--cell contacts during time-lapse fluorescence imaging. Images are from representative experiments. (See also Video 2 and Video 3, available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>).](200404160f7){#fig7}

The talin head domain binds to the cytoplasmic domain of the LFA-1 β~2~ subunit, induces conformational change in the extracellular domain of LFA-1, and increases its affinity for ICAM-1 ([@bib15]). K562 cells stably transfected with LFA-1 grow as single cells, whereas additional transfection of the talin head domain ([@bib15]) induced homotypic cell aggregates during growth in culture. When these cells are gently suspended, many of the cells remain homotypically adherent and show macroclustered LFA-1 at cell--cell contact interfaces ([Fig. 7](#fig7){ref-type="fig"} C). Other suspended cells are free cells, and some of these have macroclustered LFA-1, presumably at recently disrupted sites of cell--cell contact ([Fig. 7](#fig7){ref-type="fig"} C). The dependence of macroclustering on cell--cell contact is readily demonstrated by vigorously pipetting the cells so they are resuspended as single cells. At time 0 at 37°C, most cells show macroclustered LFA-1 ([Fig. 7](#fig7){ref-type="fig"} E), but after 10 min of incubation at 37°C, the LFA-1 diffused into an even distribution pattern ([Fig. 7, D and E](#fig7){ref-type="fig"}; Video 2, available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>). Conversely, cells with no preformed LFA-1 macroclustering could be seen to form macroclusters within 15 min of establishing homotypic cell aggregates ([Fig. 7](#fig7){ref-type="fig"} F and Video 3). LFA-1 in cells in the same field not involved in homotypic cell adhesions remained evenly distributed over the duration of the experiment ([Fig. 7](#fig7){ref-type="fig"} F and Video 3). These results demonstrate that macroclusters are ligand-dependent, mass-action--driven assemblies.

To extend our study on the relationship between integrin conformational change and valency regulation to nontransfected, primary T lymphocytes, we assessed the effects of two distinct classes of small molecule allosteric LFA-1 antagonists ([@bib33]). The α I allosteric antagonists, exemplified here with BIRT377, bind to the α~L~ I domain and stabilize it in the low affinity, closed conformation. By contrast, the α/β I-like allosteric antagonists, exemplified here with XVA143, bind to the MIDAS of the β~2~ I-like domain and also in part to the α~L~ subunit, and block the communication of conformational signals from the β~2~ I-like domain to the α~L~ I domain ([@bib33]). Because of these different modes of action, we hypothesized that α I allosteric antagonists would inhibit both affinity and valency regulation of LFA-1, whereas α/β I-like allosteric antagonists would only inhibit affinity regulation. Indeed, the α I allosteric antagonist BIRT377 totally abolished adhesion to ICAM-1 induced by all agents tested (i.e., Mn^2+^, PMA, cytochalasin D, and latrunculin A), both with cultured primary human T lymphocytes ([Fig. 8](#fig8){ref-type="fig"} A) and K562 transfectants expressing wild-type α~L~β~2~ ([Fig. 8](#fig8){ref-type="fig"} B). By contrast, XVA143 effectively blocked adhesion stimulated by Mn^2+^ and PMA, but did not inhibit adhesion stimulated by cytochalasin D or latrunculin A ([Fig. 8, A and B](#fig8){ref-type="fig"}). These results demonstrate that PMA- and Mn^2+^-stimulated adhesion (but not cytochalasin D-- and latrunculin A--stimulated adhesion) requires conformational communication between the α~L~ I- and β~2~ I-like domains, and that in all cases, the α~L~ I domain must transit out of the closed, low affinity conformation to support adhesion.

![**Affinity regulation, but not valency regulation, depends on conformational communication within the extracellular domain of LFA-1 as shown with both primary T lymphocytes and K562 transfectants.** V-bottom adhesion assays were with primary human T lymphocytes (A), or with K562 cells stably expressing either wild-type α~L~β~2~ (B) or α~L~-E310A/β~2~ (C). T lymphocytes were preincubated with 1 mM Mn^2+^, 1 μM PMA, 1 nM cytochalasin D, or 100 nM latrunculin A, and K562 cells were preincubated with 1 mM Mn^2+^, 1 μM PMA, 1 μM cytochalasin D, or 1 μM latrunculin A. Assays were in the presence of 20 μM BIRT377, 1 μM XVA143, or an equivalent concentration of DMSO as control. Data are mean ± SEM of three experiments, each in duplicate or triplicate.](200404160f8){#fig8}

α~L~ Glu-310 communicates conformational change between the α~L~ I- and β~2~ I-like domains ([@bib44]). Mutation of α~L~ Glu-310 abrogates adhesion of LFA-1 to ICAM-1 substrates stimulated by activating mAb, Mg^2+^/EGTA, Mn^2+^, and PMA ([@bib26]); the effect on adhesion stimulated by cytochalasin D and latrunculin A has not previously been examined. We confirmed that Mn^2+^ and PMA do not stimulate adhesion through the α~L~-E310A/β~2~ mutant ([Fig. 8](#fig8){ref-type="fig"} C). In a remarkable contrast, cytochalasin D and latrunculin A activated adhesion through α~L~-E310A/β~2~ ([Fig. 8](#fig8){ref-type="fig"} C) to the same extent as for wild-type α~L~/β~2~ ([Fig. 8](#fig8){ref-type="fig"}, compare C with B). Furthermore, adhesion by the mutant stimulated by cytochalasin D and latrunculin A was unaffected by XVA143, and completely inhibited by BIRT377 ([Fig. 8](#fig8){ref-type="fig"} C). Both compounds bind to α~L~-E310A/β~2~ ([@bib32]). These findings demonstrate that adhesion promoted by disruption of the actin cytoskeleton requires local conformational change in the ligand-binding α~L~ I domain, but not conformational coupling to other integrin domains, i.e., priming (inside-out signaling) is not required.

Discussion
==========

In this paper we have addressed whether LFA-1 clustering occurs independently of, or as a consequence of, ligand binding, and whether clustering can be induced by alterations in integrin conformation. Before the discovery of the structural basis ([@bib34]) for intermediate affinity states of LFA-1 ([@bib21]; [@bib34]), clustering was widely accepted as the mechanism of action for many agents such as PMA and actin microfilament disrupters that, in contrast to Mn^2+^, induce adhesiveness of LFA-1 but not detectable high affinity binding to ICAM-1 ([@bib8]). Because of the perceived need to explain this disparity, it was generally accepted prima facie that clusters would be preformed. Our analysis of both macro- and microclustering demonstrate that, in the absence of either a multivalent ligand on a substrate or homotypic cell aggregation, PMA, cytochalasin D, latrunculin A, and chemokine treatments do not alter integrin distribution patterns despite their ability to promote significant adhesion ([Fig. 9](#fig9){ref-type="fig"}). These agents failed to increase FRET between neighboring α~L~-mCFP/β~2~ and α~L~-mYFP/β~2~ molecules or between neighboring α~L~/β~2~-mCFP and α~L~/β~2~-mYFP molecules. This agrees with our previous observation that stimulation with chemokines, Mn^2+^ plus sICAM-1, and PMA induced separation between the cytoplasmic domains of the α~L~ and β~2~ subunits as shown by a decrease in FRET between α~L~-mCFP/β~2~-mYFP in individual LFA-1 heterodimers ([@bib15]). Previous experiments designed to assess integrin macroclustering were often performed under conditions that promote robust homotypic cell aggregation; no effort was made to prevent homotypic adhesion, the effect of homotypic adhesion or a preincubation period in monodisperse cell suspension on cluster formation was not tested, and somtimes it was emphasized that after activation cells were fixed immediately before preparation for microscopy.

![**Schematic of integrin affinity, diffusivity, and clustering.** Inside-out signaling alters integrin affinity and cytoskeletal disruption alters integrin diffusity. How these regulate binding to ligand and the consequences for micro- and macroclustering are shown. Note that the additional effect of integrin redistribution in polarized cells was not studied here and is not shown.](200404160f9){#fig9}

The novel finding presented here that clustering of LFA-1 follows and does not precede ligand binding ([Fig. 9](#fig9){ref-type="fig"}, B--D) places the biology of β~2~ integrins in much better agreement with that of β~1~ and β~3~ integrins. Clustering of α~IIb~β~3~ on activated platelets is observed in the presence (but not the absence) of fibrinogen, a multivalent ligand ([@bib20]; [@bib12]). At concentrations that activate adhesion, PMA, cytochalasin D, and latrunculin A do not promote detectable microclustering of α~IIb~β~3~, although these agents do enhance microclustering in response to soluble fibrinogen binding ([@bib4]). Furthermore, clustering of integrins α~IIb~β~3~, α~V~β~3~, and α~5~β~1~ into focal adhesions follows rather than precedes adhesion ([@bib1]; [@bib17]; [@bib31]).

We found that microclustering was readily induced by binding of soluble, multivalent ICAM-1 complexes ([Fig. 9](#fig9){ref-type="fig"} B). Moreover, ICAM-1--mediated homotypic cell aggregation induced striking macro- and microclustering at the cell--cell interface ([Fig. 9](#fig9){ref-type="fig"} C). Thus, binding to multivalent ligand drives integrin redistribution. Investigation of adhesion to ICAM-1--bearing substrates revealed that adhesion promoted by the selective disruption of cytoskeletal constraints with cytochalasin D or latrunculin A ([Fig. 9](#fig9){ref-type="fig"} D) resulted in substantially greater accumulation of LFA-1 at the substrate contact interface than adhesion stimulated by selective enhancement of affinity with Mn^2+^. Thus, releasing integrins from cytoskeletal constraints facilitates not ligand-independent clustering, but ligand-dependent accumulation of integrins at the site of substrate contact, i.e., adhesion strengthening.

Based primarily on studies with peptides in detergent micelles, it was hypothesized that separation of integrin α and β subunit transmembrane domains during the global conformational shift to the open high affinity state would unmask homophilic dimerization and trimerization sites in the transmembrane segments of α~IIb~ and β~3~, respectively, driving the oligomerization of integrins on the cell surface ([@bib19]). We have been able to directly test this hypothesis in intact cells with full-length integrins. Under conditions previously shown ([@bib15]) and confirmed here to induce separation of the α~L~ and β~2~ cytoplasmic domains, we found with FRET and confocal fluorescence microscopy that no macro- or microclustering occurred, as long as homotypic cell aggregation was prevented. In agreement, independent assays demonstrate that after activation in intact cells, the α~IIb~ and β~3~ transmembrane domains separate, and homo-multimers of α~IIb~ or β~3~ transmembrane domains are not detected ([@bib25]). These results do not preclude the possibility that once ligand binding--driven microclustering takes place, homomeric interactions between transmembrane domains could stabilize adhesion assemblies.

Our results with α I- and α/β I-like allosteric antagonists demonstrate that these are excellent reagents for distinguishing between affinity and valency regulation of LFA-1 adhesiveness, and enabled us to extend our studies to untransfected T lymphocytes. The ability of the α/β I-like allosteric antagonist XVA143 to inhibit Mn^2+^ and PMA-stimulated adhesions demonstrates that activation by these agents requires conformational communication between the α I- and β~2~ I-like domains. PMA activates LFA-1 adhesiveness by virtue of its activation of PKC ([@bib9]), i.e., by integrin priming or inside-out signaling. By contrast, the lack of inhibition by XVA143 of cytochalasin D-- and latrunculin A--stimulated adhesion demonstrates that activation by these agents does not require conformational change in response to signals from within the cell. Exactly the same pattern of inhibition by XVA143 was found with K562 transfectants and T lymphocytes, demonstrating the generality of the findings. The requirement for conformational communication between the α I- and β~2~ I-like domains for activation of adhesion by Mn^2+^ and PMA, but not cytochalasin D or latrunculin A, was confirmed with the α~L~-E310A mutation ([@bib32]; [@bib44]). The inhibition by the α I allosteric antagonist BIRT377 of adhesion stimulated by all agents demonstrates that even adhesion stimulated by cytochalasin D and latrunculin A requires conversion to the high affinity, open conformation of the α~L~ I domain. In the case of these two agents, conformational change is driven by binding to ICAM-1 rather than inside-out signaling.

Our data demonstrating that PMA activates adhesiveness predominantly through affinity rather than valency regulation are consistent with data in previous reports, even though the conclusions have differed. PMA enhances diffusion on the cell surface of LFA-1, but whether this is the cause of its enhancement of adhesiveness of LFA-1 was not determined ([@bib16]). Indeed, the greater adhesion stimulated by PMA than cytochalasin D, the enhancement by PMA of cytochalasin D--stimulated adhesion, and the lack of enhancement by cytochalasin D of PMA-stimulated adhesion are all consistent with PMA contributing to both affinity and valency regulation ([@bib16]). Furthermore, the complete abolition of PMA-stimulated adhesion (but not cytochalasin D-- or latrunculin A--stimulated adhesion) by α/β I-like allosteric antagonist and the αL-E310A mutation demonstrate a requirement for affinity regulation for PMA-stimulated adhesion. The finding here that Mn^2+^ induces both activation epitopes in the β~2~ I-like domain in the headpiece and the β~2~ I-EGF2 domain near the bend in β~2~ leg, whereas PMA induces the activation epitope in the I-EGF2 domain ([@bib23]) and not in the I-like domain, suggests that Mn^2+^ induces the extended, high affinity conformation of α~L~β~2~ with an open headpiece, whereas PMA induces the extended, intermediate affinity conformation of α~L~β~2~ with a closed headpiece ([@bib32]). The higher affinity of LFA-1 on Mn^2+^-stimulated cells than on PMA-stimulated cells is in complete agreement with the stronger stimulation by Mn^2+^ than by PMA of adhesion by K562 transfectants demonstrated here, despite the lesser accumulation of LFA-1 in the adhesion zone stimulated by Mn^2+^ than by PMA. Our results are also consistent with the findings that PMA stimulates an increase in the monomeric affinity of LFA-1 for soluble ICAM-1 that cannot be detected in direct binding assays, but can readily be detected by displacement by soluble ICAM-1 of ^125^I-labeled Fab fragments to the α~L~ I domain ([@bib21]), and that Mn^2+^ but not PMA stimulates an increase in affinity of LFA-1 for ICAM-1 that can be detected in direct binding assays ([@bib36]).

In the context of leukocyte firm adhesion to the vascular endothelium, it is critical to understand the mechanistic basis for the transition from rolling to arrest, as this represents the initial, integrin-dependent event in development of inflammation. Given our observation that integrin macro- and microclustering occurs only after binding to multivalent ligands, it is tempting to speculate that modulation of the conformational equilibrium plays the critical and limiting role in formation of integrin--ligand bonds that initiate firm adhesion, and that this is followed in a mass-action--dependent, diffusion-limited manner by accumulation of LFA-1 at the substrate contact interface, resulting in adhesion strengthening ([Fig. 9](#fig9){ref-type="fig"} C). Our studies with K562 cells do not define the role of active redistribution of LFA-1 during leukocyte polarization and migration; nonetheless, differential concentration of LFA-1 to the lamellapodium in polarized cells, a form of valency regulation, may work in concert with affinity regulation ([@bib13]). Furthermore, regulation of the diffusiveness of LFA-1 may play an important role in adhesion strengthening.

Materials and methods
=====================

Materials
---------

PMA, cytochalasin D, and latrunculin A were from Calbiochem. Cy3-conjugated goat anti--mouse IgG and goat anti--human IgA were from Zymed Laboratories. Antibody conjugation to Cy3 was according to manufacturer\'s instructions (Amersham Biosciences). The small molecule LFA-1 inhibitor XVA143 was from Paul Gillespie (Roche) ([@bib33]). The inhibitor BIRT377 was from Terence Kelly (Boehringer Ingelheim Pharmaceuticals Inc.). Sources for anti--human α~L~ and β~2~ mAbs TS2/4 and CBR-LFA1/7 have been described previously ([@bib24]). KIM127 and m24 mAbs were provided by M. Robinson (Celltech Limited) and N. Hogg (Imperial Cancer Fund, Oxford, England), respectively.

Cell culture and transfections
------------------------------

Culture and transient transfection of K562 cells was as described previously ([@bib15]). K562 stable transfectants expressing wild-type α~L~β~2~ were described previously ([@bib24]).

Peripheral blood mononuclear cells were prepared by Ficoll-Hypaque (Sigma-Aldrich) buoyant density centrifugation of 50 ml fresh human blood. Lymphocytes were cultured at 10^5^/ml in RPMI 1640 supplemented with 10% FBS and PHA (1 μg/ml) for 3 d, followed by culture in IL-15 (20 ng/ml) for 4--7 d. Flow cytometry demonstrated that these cells were 97% CD3 positive.

DNA plasmids and constructs
---------------------------

Generation of α~L~-mCFP and β~2~-mYFP was previously described ([@bib15]). α~L~-mYFP and β~2~-mCFP were generated by AgeI--NotI digestion of α~L~-mCFP and β~2~-mYFP, followed by swapping and religation of the 0.7-kb mCFP and mYFP inserts, respectively.

Flow cytometry
--------------

Flow cytometric analysis was as described previously ([@bib23]). R-phycoerythrin--conjugated anti--mouse IgG (BD Biosciences) was used as secondary antibody for detection.

Cell adhesion assays
--------------------

V-bottom cell adhesion assay was as described previously ([@bib15]). 1 mM MnCl~2~, 1 μM PMA, 1 μM cytochalasin D, or 1 μM latrunculin A was used for K562 cells. For human T lymphocytes, 1 mM MnCl~2~, 1 μM PMA, 1 nM cytochalasin D, or 100 nM latrunculin A was used. Titrations demonstrated that concentrations of 1 and 100 nM for cytochalasin D and latrunculin A, respectively, were optimal for adhesion of T lymphocytes. ICAM-1--coated plates containing equal vol of L15 medium/2.5% FCS, with identical concentrations of activating agents as in each of the cell samples, were preequilibrated to 37°C. Cells were resuspended 5--10 times with a micropipette and were added to the plates followed by immediate centrifugation at 200 *g* for 15 min at RT. After centrifugation, nonadherent cells that accumulated at the center of the V-bottom were quantified on a fluorescence plate reader. Flat-bottom cell adhesion assay was as described previously ([@bib22]).

Shear detachment assay was largely as described previously ([@bib32]). In brief, cells were allowed to settle onto ICAM-1--coated coverslips with or without brief centrifugation (200 *g* for 1 min) to enforce interaction with substrate, and then the cells were incubated at 37°C for 30 min.

Binding of soluble ICAM-1
-------------------------

Soluble ICAM-1 binding assay was as described previously ([@bib32]).

Cellular imaging
----------------

For imaging adhesion to ICAM-1 substrates, glass surfaces of ΔT4 chambers (Bioptechs) were coated with human tonsil ICAM-1 as in adhesion assays described above. K562 cells expressing wild-type α~L~β~2~ were incubated with or without MnCl~2~, PMA, cytochalasin D, or latrunculin A, as above, and then allowed to contact ICAM-1 substrates either by gravity or brief centrifugation (200 *g* for 1 min). After a 30-min incubation at 37°C, surfaces were washed once with PBS and cells were fixed with 3.7% formaldehyde/PBS for 10 min at RT. Cells were then stained with TS2/4 mAb to αL directly conjugated to Cy3 and washed with PBS. IRM, DIC, and FRET imaging was conducted on an epifluorescence microscope (Axiovert S200; Carl Zeiss MicroImaging, Inc.) at RT, using 63× oil objective coupled to an Orca CCD (Hamamatsu Corporation). Confocal imaging, consisting of serial Z-sections of 0.5-μm thickness, was performed with a laser-scanning confocal system (Radiance 2000; Bio-Rad Laboratories) coupled to a microscope (BX50BWI; Olympus) and a 100× water immersion objective. All image processing was performed with OpenLab software (Improvision).

FRET
----

FRET was essentially as described previously ([@bib15]). 10^6^/ml cells were washed and resuspended with 1 ml L15 medium supplemented with 2.5% FCS and incubated in 6-well plates with or without 1 mM MnCl~2~, 1 μM PMA, 1 μM cytochalasin D, 1 μM latrunculin A, or 100 μg/ml soluble ICAM-1 (D1-D5) at 37°C for 30 min. Then cells were fixed with 3.7% formaldehyde/PBS for 10 min at RT. Fields, usually containing one to two transiently transfected cells, were illuminated with a 100-W mercury arc lamp through a ND 1.5 filter and a 63× oil immersion objective lens. Cells with relatively similar intensity levels of CFP and YFP were selected for experiments. After image registration and background subtraction, the CFP signal in a ring outlining the cell membrane was randomly divided into 10--15 regions of interest (ROIs) that were each analyzed independently. ROIs exhibiting saturation in either the donor or acceptor channels were eliminated from the analysis. FRET efficiency (E) was calculated as $$\documentclass[10pt]{article}
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\begin{equation*}{\mathrm{Eq}}.\;1\end{equation*}\end{document}$ (see Results) using Prism (San Diego, CA) and Lineweaver-Burke plots, i.e., 1/E = 1/E~max~ + K/E~max~ × 1/F. K was calculated from the slope of K/E~max~ and 1/E~max~ at the y intercept. K values are given ± SD. The curves for $\documentclass[10pt]{article}
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\begin{equation*}{\mathrm{Eq}}.\;2\end{equation*}\end{document}$ shown in the figures use the K and E~max~ values calculated from the Lineweaver-Burke plots.

Calculated FRET efficiencies were plotted as a function of YFP acceptor intensity for ∼100 individual ROIs from 10--15 individual cells. Freshly prepared cells were used for each photobleach, and each dataset contained ROIs from at least three separate experiments.

Online supplemental material
----------------------------

Fig. S1 shows evidence for Mn^2+^-stimulated ligand binding and effect on LFA-1 macroclustering. Fig. S2 shows coexpression of CFP- and YFP-tagged LFA-1 and CXCR4. Fig. S3 shows that concentrations of cytochalasin D and latrunculin A that promote adhesion induce only partial disruption of the actin cytoskeleton. Fig. S4 shows that disruption of cytoskeletal constraints increases lateral mobility of LFA-1. Video 1 shows that chemokine SDF-1--activated binding of multimeric ICAM-1 does not induce detectable macroclustering of LFA-1. Video 2 shows reversal of LFA-1 clusters after disruption of homotypic cell aggregation. Video 3 shows that homotypic cell aggregation promotes LFA-1 clustering at the cell--cell contact interface. Online supplemental material available at <http://www.jcb.org/cgi/content/full/jcb.200404160/DC1>.
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